Cannell Capital XILIO THERAPEUTICS INC ownership

XILIO THERAPEUTICS INC's ticker is and the CUSIP is 98422T100. A total of 33 filers reported holding XILIO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Cannell Capital ownership history of XILIO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$134,5450.00%